Taiwan Liposome Company, Ltd. announced that its Board of directors resolved to set up TLC Biopharmaceuticals (Japan) Company, Ltd. in Japan, which is owned 100% by the company. The capital of this subsidiary is ¥10,000,000.
Taiwan Liposome Company, Ltd.
Equities
4152
TW0004152004
Biotechnology & Medical Research
1st Jan change | Capi. | |
---|---|---|
+20.12% | 126B | |
+25.25% | 119B | |
+25.56% | 27.95B | |
-19.51% | 20.5B | |
-14.36% | 17.12B | |
-15.63% | 16.1B | |
-46.67% | 14.97B | |
+11.89% | 14.84B | |
+57.74% | 14.38B |